The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The Nationwide Cancer Genome Screening Project in Japan SCRUM-Japan GI-SCREEN: Efficient identification of cancer genome alterations in advanced non-colorectal (Non-CRC) gastrointestinal cancer.
 
Atsuo Takashima
No Relationships to Disclose
 
Wataru Okamoto
Research Funding - MSD
 
Shuichi Hironaka
Honoraria - Taiho Pharmaceutical; Yakult Honsha
 
Takeshi Kato
Speakers' Bureau - Bayer; Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - Chugai Pharma; Yakult Honsha
Expert Testimony - Lilly
Travel, Accommodations, Expenses - Eisai
 
Yoshito Komatsu
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Speakers' Bureau - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; Novartis; Pfizer; Taiho Pharmaceutical; Takeda; Yakult Pharmaceutical
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); Lilly Japan (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Pharmaceutical (Inst)
 
Takeshi Kajiwara
No Relationships to Disclose
 
Naoki Izawa
No Relationships to Disclose
 
Taito Esaki
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Daiichi Sankyo; Lilly Japan; Merck Serono; MSD; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
 
Hiroki Hara
Honoraria - Chugai Pharma; Lilly; Merck Serono; Taiho Pharmaceutical; Yakult Honsha
Consulting or Advisory Role - Chugai Pharma; Ono Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Ryota Nakanishi
No Relationships to Disclose
 
Yoshiyuki Yamamoto
Honoraria - Taiho Pharmaceutical; Takeda
 
Hiromichi Ebi
No Relationships to Disclose
 
Shigenori Kadowaki
Honoraria - Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Yakult Honsha
Research Funding - Lilly Japan (Inst); Taiho Pharmaceutical (Inst)
 
Takeshi Kuwata
No Relationships to Disclose
 
Satoshi Fujii
No Relationships to Disclose
 
Toshihiko Doi
Consulting or Advisory Role - AstraZeneca; Bayer Yakuhin; Chugai Pharma; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; MSD; Nippon Boehringer Ingelheim; Novartis; Otsuka
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Eisai (Inst); Janssen (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sanofi (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Atsushi Ohtsu
Employment - Celgene (I)
Research Funding - Bristol-Myers Squibb
 
Kohei Shitara
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Novartis; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bayer (Inst); Chugai Pharma (Inst); Lilly (Inst); Takeda (Inst)
Research Funding - Bayer (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Lilly (Inst); MSD (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Yakult Pharmaceutical (Inst)
 
Takayuki Yoshino
Research Funding - Dainippon Sumitomo Pharma (Inst)